The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Open accessPublished version of a preprint
Abstract
BACKGROUND: Circulating lipoprotein lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. Using genetic instruments for lipoprotein lipid traits implemented through multivariable Mendelian randomisation (MR), we sought to compare their causal roles in the aetiology of CHD. METHODS AND FINDINGS: We conducted a genome-wide association study (GWAS) of circulating non-fasted lipoprotein lipid traits in the UK Biobank (UKBB) for low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoprotein B to identify lipid-associated single nucleotide polymorphisms (SNPs). Using data from CARDIoGRAMplusC4D for CHD (consisting of 60,801 cases and 123,504 controls), we performed univariable and multivariable MR analyses. Similar GWAS and MR analyses were conducted for high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I. The GWAS of lipids and apolipoproteins in the UKBB included between 393,193 and 441,016 individuals in whom the mean age was 56.9 y (range 39-73 y) and of whom 54.2% were women. The mean (standard deviation) lipid concentrations were LDL cholesterol 3.57 (0.87) mmol/L and HDL cholesterol 1.45 (0.38) mmol/L, and the median triglycerides was 1.50 (IQR = 1.11) mmol/L. The mean (standard deviation) values for apolipoproteins B and A-I were 1.03 (0.24) g/L and 1.54 (0.27) g/L, respectively. The GWAS identified multiple independent SNPs associated at P < 5 × 10-8 for LDL cholesterol (220), apolipoprotein B (n = 255), triglycerides (440), HDL cholesterol (534), and apolipoprotein A-I (440). Between 56%-93% of SNPs identified for each lipid trait had not been previously reported in large-scale GWASs. Almost half (46%) of these SNPs were associated at P < 5 × 10-8 with more than one lipid-related trait. Assessed individually using MR, LDL cholesterol (odds ratio [OR] 1.66 per 1-standard-deviation-higher trait; 95% CI: 1.49-1.86; P < 0.001), triglycerides (OR 1.34; 95% CI: 1.25-1.44; P < 0.001) and apolipoprotein B (OR 1.73; 95% CI: 1.56-1.91; P < 0.001) had effect estimates consistent with a higher risk of CHD. In multivariable MR, only apolipoprotein B (OR 1.92; 95% CI: 1.31-2.81; P < 0.001) retained a robust effect, with the estimate for LDL cholesterol (OR 0.85; 95% CI: 0.57-1.27; P = 0.44) reversing and that of triglycerides (OR 1.12; 95% CI: 1.02-1.23; P = 0.01) becoming weaker. Individual MR analyses showed a 1-standard-deviation-higher HDL cholesterol (OR 0.80; 95% CI: 0.75-0.86; P < 0.001) and apolipoprotein A-I (OR 0.83; 95% CI: 0.77-0.89; P < 0.001) to lower the risk of CHD, but these effect estimates attenuated substantially to the null on accounting for apolipoprotein B. A limitation is that, owing to the nature of lipoprotein metabolism, measures related to the composition of lipoprotein particles are highly correlated, creating a challenge in making exclusive interpretations on causation of individual components. CONCLUSIONS: These findings suggest that apolipoprotein B is the predominant trait that accounts for the aetiological relationship of lipoprotein lipids with risk of CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypertriglyceridemia is indirectly linked with changes in HDL-C and LDL-C composition that are conducive to accelerated atherogenesis.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [312]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence from prospective longitudinal cohort studies and Mendelian randomization support a strong, dose-dependent relationship between LDL-C levels and ASCVD incidence [2, 3].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From this perspective, triglycerides chiefly index TRL particle burden rather than act as an independent atherogen, and causal inferences often attenuate when apoB is accounted for in multivariable genetic analyses [2].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the same time, it is important to recognize that apoB remains the most informative single summary measure of atherogenic risk, as LDL apoB numerically dominates total apoB in most individuals; accordingly, the benefits of lipid-lowering therapy appear to correlate more closely with reductions in apoB (particle number) than with triglyceride lowering alone [2, 18, 19].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We also highlight that apoB is the most robust integrative metric of atherogenic particle exposure, with some trial benefits aligning more strongly with apoB reduction than with triglyceride lowering alone [2, 18].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measured
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. (2011) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 13,726
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The repertoire of robust univariable MR approaches [51] that seek to act as sensitivity analyses for potential unbalanced horizontal pleiotropy each make a different series of assumptions [53].”
BackgroundMethodThe UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Research works printed but not linked: 1
- D Fry, 2019, Companion Document to Accompany Serum Biomarker Data, UK Biobank Biomarker Project
Cited by
Items 701–800 of 903
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22600970
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601285
Additional file 1 of The genetic etiology of body fluids on chronic obstructive airways disease
Cheng, Z. J., Wu, H., Chang, Z., Cheng, J., Wang, S., Liu, C., Zhang, Y., Xu, S., Wan, Q., Ron, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25034422
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601282
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601000
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601270
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601024
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601036
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601186
Si, J., Meir, A. Y., Hong, X., Wang, G., Huang, W., Pearson, C., Adams, W. G., Wang, X., & Liang, L. (2023) · Figshare · doi:10.6084/m9.figshare.24022849
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601213
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601225
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22600958
Schlosser, P., Zhang, J., Liu, H., Surapaneni, A., Rhee, E. P., Arking, D. E., Yu, B., Boerwinkle, E., Welling, P. A., Chatterjee, N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23583591
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · UWA Profiles and Research Repository (UWA) · doi:10.6084/m9.figshare.22601087
Thu, N. H. H., Linh, N. T., Thương, M. T. H., Dương, N. T., & Hà, N. H. (2024) · Vietnam Journal of Biotechnology · doi:10.15625/1811-4989/19504
Shen, Q., Liu, Z., Huang, H., Liang, Y., Chen, M., & Xu, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4226794/v1
Women in Cardiovascular Genetics and Systems Medicine
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4796-0
Enhancing Coronary Heart Disease Risk Prediction with Machine Learning and Deep Learning
Padmaja, M. P. S. H. R., Sudarshan, V., Babu, K. S., Lakshman, M. M. K., & Akhilandeswari, K. (2024) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2024.61185
Chen, P., Song, Z., Ran, D., & Li, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4337384/v1
Fatumo, S., Silva, S., Hughes, D., Kintu, C., Tcheandjieu, C., & Nitsch, D. (2024) · Research Square · doi:10.21203/rs.3.rs-4435794/v1
Liu, M., Chen, X. '., Yu, C., Chen, J., Zhen, P., & Liu, Z.-P. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1383646
Vicuña, L., Barrientos, E., Leiva-Yamaguchi, V., Alvares, D., Verónica Mericq, G., Pereira, A., & Eyheramendy, S. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae098
Association between type 2 diabetes mellitus and gastric cancer: A Mendelian randomization studyPreprint
Yuan, Y., Li, T., Peng, G., & Jiang, D. (2024) · Research Square · doi:10.21203/rs.3.rs-4498488/v1
Ieki, H., Ito, K., Zhang, S., Koyama, S., Kjellberg, M., Yoshida, H., Kurosawa, R., Matsunaga, H., Miyazawa, K., Enzan, N., et al. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005341
Huang, Y., Dong, W., Zhong, M., Li, Q., & Jiang, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4437336/v1
Birthweight influences liver structure, function and disease risk: Evidence of a causal association
Peng, L., Shen, J., Li, L., Liu, J., Jiang, X., Zhang, G., & Li, Y. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15910 · Cited by 2
Kontush, A. (2024) · Wiley eBooks · doi:10.1002/9781394158393.ch9b
Liu, X., Zhou, X., Wang, J., Cai, A., Zhang, Y., Zhang, J., Wu, Z. R., & Zhu, B. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2397722 · Cited by 1
Potential Molecular Mechanisms and Metabolic Networks in Red Ginseng-induced “ Shanghuo ” (上火)
Yang, Z. Y., Zhang, Y., Xie, R., Xie, Z., Zhao, K., Fan, Y., & Zhao, T. (2024) · Natural Product Communications · doi:10.1177/1934578x241291396
Leite, J. M. R. S., Trindade, L. A. I., Pereira, J. L., de Souza, C. A., Soler, J. M. P., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Healthcare · doi:10.3390/healthcare12222275
Wang, Q., Yang, Z., Zhao, P., Lin, X., Wen, S., Zhang, X., & Xu, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5080363
Yang, Z., Xiao, W., Zhuang, Z., Zhan, S., Wang, M., Wu, Y., Huang, T., & Li, R. (2025) · PubMed Central · doi:10.6133/apjcn.202502_34(1).0004 · Cited by 1
Wu, Q., Xu, Z., & Cai, E. (2025) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.12.070
Mao, W., Wang, G., Wang, X., Shen, Y., Yuan, S., Wang, L., Yang, H., Li, Y., Chen, K., Liu, J., et al. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70056
Reply to: Methodological and Interpretational Issues in the PsyRiskMR Database
Li, X., & Xia, J. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.887
Xin, J., Xu, Z., Zhang, F., Sun, Y., Wang, X., Wu, C., & Zhao, L. (2025) · Medicine · doi:10.1097/md.0000000000041771
Wang, J., Su, J., Liu, D., & Ma, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01701-z
Genetic Analysis Reveals a Protective Effect of Sphingomyelin on Cholelithiasis
Mao, K., Li, A., Liu, H., Gao, Y., Wang, Z., Wang, X., Liu, S., Gao, Z., Quan, J., Shao, M., et al. (2025) · Genes · doi:10.3390/genes16050523
Liu, W., Su, Q., Nanna, M. G., Guan, X., Ma, N., Liu, X., Su, P., & Xie, B. (2025) · The FASEB Journal · doi:10.1096/fj.202500032rrr
Yang, W., Wang, X., Yang, H., & Hao, D. (2025) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2025.07(05).12
Gao, Y., Wang, Y., Su, J., Zhang, C., Zhang, Q., & Chen, Z. (2025) · Health Science Reports · doi:10.1002/hsr2.70875
Wang, Q., Yang, Z., Zhao, P., Lin, X., Wen, S., Zhang, X., & Xu, Y. (2025) · Clinical Medicine and Pharmacology · doi:10.70731/91pd8g49
Tratamiento de la hipertrigliceridemia para la reducción del riesgo cardiovascular
Guijarro, C. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500816
Sun, A., Chen, Y., Wu, Y., Li, Z. L., Zhang, J., & Liu, Z. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm31395
Treatment of hypertriglyceridemia to reduce cardiovascular risk
Guijarro, C. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500816
Liu, X., Chen, J., Zhou, S., & Lin, J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5343605
Evans, B. L., Garner, T., Leonibus, C. D., Wright, L., Sharps, M. C., Wearing, O. H., Ripley, D. M., Shiels, H. A., Hurlstone, A. F. L., Clayton, P., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05784-9 · Cited by 1
Zhang, B., Yang, B., Xiu, W., Xue, D., Zheng, Y., Wei, J., & Dai, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-12369-w · Cited by 2
Dhabuwala, A., Senapati, S. G., Lapsiwala, B. J., Wala, L., Madhavaram, N. J., Kolli, D., & Desai, R. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001006
Shi, H., Li, T., & Xu, Y. L. N. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2548488
Association Between PNPLA3 Inhibition and Gout: A Drug Target Mendelian Randomization Study
Wang, C., Guo, P., Liu, X., Xu, X., Zou, L., Shi, M., Guo, Q., Wen, Q., & Yang, C. (2025) · International Journal of Endocrinology · doi:10.1155/ije/6664846
Wu, X., Cheng, H., Li, J., & Wang, L. (2025) · Medicine · doi:10.1097/md.0000000000044351
Shen, R., Lyu, Y., Yang, C., Zou, S., & Xu, Y. (2025) · Medicine · doi:10.1097/md.0000000000044482
Xu, Y., Si, Y., Li, N., Wang, R., Hua, M., Xiu, L., Zhao, H., & Ren, Q. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1644496 · Cited by 1
Rizos, C. V., Kolovou, G. D., Kolovou, V., Liamis, G. L., Skoumas, I., Rallidis, L. S., Garoufi, A., Sfikas, G., Penopoulos, A., Skalidis, E. I., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04427-0
Fan, L., Jiang, H., & Zhang, Z. (2025) · BioData Mining · doi:10.1186/s13040-025-00484-3 · Cited by 1
Sex-specific disease association and genetic architecture of retinal vascular traitsPreprint
Bergmann, S., Böttger, L., Bontempi, D., Trofimova, O., Beyeler, M. J., Bors, S., Iuliani, I., Quintas, I., & Presby, D. M. (2025) · Research Square · doi:10.21203/rs.3.rs-7472272/v1 · Cited by 3
Pham, K., Mulugeta, A., Lumsden, A. L., & Hyppönen, E. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110160 · Cited by 1
Admixture Mapping of Lipid Traits in Hispanic Americans
Ding, K., Johar, A., Zaidi, A. A., Crane, P. K., Edwards, D. R. V., Jarvik, G. P., Karlson, E. W., Rosenthal, E. A., Stanaway, I. B., Weng, C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.036650
Li, X., Jiang, M., Zhao, L., Chen, Z., Shao, Y., Lu, T., Zhang, D., Li, J., & Wang, L. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02797-y
Murrin, O., Voller, B., Woodward, R. M., Carrasco-Ribelles, L. A., Türkmen, D., Gu, Q., Boddy, K., Farmer, L., Mancini, M., Khalid, S., et al. (2026) · Respiratory Research · doi:10.1186/s12931-026-03726-y
Additional file 4 of Variants influencing age at diagnosis of HNF1A-MODY
Ludwig‐Słomczyńska, A. H., Seweryn, M. T., Radkowski, P., Kapusta, P., Machlowska, J., Pruhova, S., Gašperíková, D., Bellanné‐Chantelot, C., Hattersley, A. T., Kandasamy, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21117371
Mei, Y., Zhao, Z., Lyu, Y., & Li, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329956
Chen, L., Sun, X., He, Y., Lu, Y., & Zheng, L. (2022) · Figshare · doi:10.6084/m9.figshare.19185835
Additional file 5 of The genetic etiology of body fluids on chronic obstructive airways disease
Cheng, Z. J., Wu, H., Chang, Z., Cheng, J., Wang, S., Liu, C., Zhang, Y., Xu, S., Wan, Q., Ron, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26669658
Chang, Z., Wang, S., Liu, K., Lin, R., Liu, C., Zhang, J., Wei, D., Nie, Y., Chen, Y., He, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26699297
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26753986
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z.-Q., Sun, N.-K., Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639749
Additional file 3 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Chen, D.-Q., Xu, W.-B., Xiao, K.-Y., Que, Z., Jinyi, F., 孙乃坤, Cai, D.-X., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26749622
Si, J., Meir, A. Y., Hong, X., Wang, G., Huang, W., Pearson, C., Adams, W. G., Wang, X., & Liang, L. (2023) · Figshare · doi:10.6084/m9.figshare.24022846
Additional file 3 of The genetic etiology of body fluids on chronic obstructive airways disease
Cheng, Z. J., Wu, H., Chang, Z., Cheng, J., Wang, S., Liu, C., Zhang, Y., Xu, S., Wan, Q., Ron, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26669652
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601279
Additional file 7 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Chen, D.-Q., Xu, W.-B., Xiao, K.-Y., Que, Z.-Q., Jinyi, F., 孙乃坤, Cai, D.-X., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26749634
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601234
Hanscombe, K. B., Persyn, E., Traylor, M., Glanville, K. P., Hamer, M., Coleman, J. R. I., & Lewis, C. M. (2021) · Figshare · doi:10.6084/m9.figshare.16969232
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z., Sun, N.-K., Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639770
Chen, X., Hong, X., Gao, W., Luo, S., Cai, J., Liu, G., & Huang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19766066
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601111
Gong, Q., & Guo, C. (2024) · Figshare · doi:10.6084/m9.figshare.24798097
Gong, Q., & Guo, C. (2024) · Figshare · doi:10.6084/m9.figshare.26652618
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z., Sun, N.-K., Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639755
Shui, X., Wen, Z., Dong, R., Chen, Z., Tang, L., Tang, W., Wu, Z., & Chen, L. (2023) · Figshare · doi:10.6084/m9.figshare.23916999
Chiu, C.-H., Hsuan, C.-F., ShihHua, L., Hung, Y.-J., Hwu, C.-M., Hee, S.-W., Lin, S.-W., Fong, S.-W., Hsieh, P. C.-H., Yang, W.-S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604497
Shui, X., Wen, Z., Dong, R., Chen, Z., Tang, L., Tang, W., Wu, Z., & Chen, L. (2023) · Figshare · doi:10.6084/m9.figshare.23917002
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26753983
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722167
Yang, G., & Schooling, C. M. (2024) · Figshare · doi:10.6084/m9.figshare.26560082
Kou, H., Wang, H., Liu, P., Wang, X., Zhu, W., Jiang, W., Hu, X., & Deng, J. (2024) · Figshare · doi:10.6084/m9.figshare.25347011
Wang, K., Shi, M., Luk, A. O. Y., Kong, A. P. S., Ronald, C. W., Li, C., Chen, L., Chow, E., & Chan, J. C. N. (2024) · Figshare · doi:10.6084/m9.figshare.26740931
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601288
Huang, K., Huang, S., & Xiong, M. D. (2024) · Figshare · doi:10.6084/m9.figshare.25107705
Chen, C., Zhang, H., Lan, Y., Yan, W., Liu, S., Chen, Y., Xie, T., Ning, J., Yan, X., Shang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26696631
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722173
Dai, H., Hou, T., Wang, Q., Hou, Y., Zhu, Z., Zhu, Y., Zhao, Z., Li, M., Lin, H., Wang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26637534
Dai, H., Hou, T., Wang, Q., Hou, Y., Zhu, Z., Zhu, Y., Zhao, Z., Li, M., Lin, H., Wang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26637537
Zhang, H., Huang, Y., Zhang, J., Su, H., & Ge, C. (2024) · Figshare · doi:10.6084/m9.figshare.24303459
Chen, Y., Bai, B., Ye, S., Gao, X., Zheng, X., Ying, K., Pan, H., & Xie, B. (2023) · Figshare · doi:10.6084/m9.figshare.24761496
Metadata
- Authors
- Richardson, T. G., Sanderson, E., Palmer, T. M., Ala-Korpela, M., Ference, B. A., Davey Smith, G., & Holmes, M. V.
- Affiliations
- University of Bristol (GB)
- University of Cambridge (GB)
- Corresponding author
- Richardson, Tom G.
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-03-23
- Volume
- 17
- Issue
- 3
- Pages
- e1003062
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC7089422
- OpenAlex
- W3012570809
- Cited by
- 843
- References
- 79
- Citations by year
- 2026: 68 · 2025: 132 · 2024: 206 · 2023: 190 · 2022: 124 · 2021: 91 · 2020: 30
- FWCI
- 67.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by-nc-nd)
- Explore Bristol Research (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_00011/1 and MC_UU-00011/2, MRC PHRU Oxford)
- UKRI (MR/S003886/1)
- National Health and Medical Research Council (APP1158958)
- Sigrid Juselius Foundation, Finland
- NIHR Cambridge Biomedical Research Centre
- British Heart Foundation (FS/18/23/33512)
- NIHR Oxford Biomedical Research Centre (Obesity theme)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- coronary artery disease, lipoprotein lipids, apolipoproteins, LDL cholesterol, triglycerides, HDL cholesterol, apolipoprotein B, apolipoprotein A-I, genetic instruments, causal inference, single nucleotide polymorphisms, genetic risk factors, UK Biobank
- MeSH terms
- Adult, Aged, Coronary Disease, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Biomarkers, Multivariate Analysis, Apolipoprotein A-I, Risk Assessment, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apolipoprotein B-100, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.